Naringin inhibits the invasion and migration of human glioblastoma cell via downregulation of MMP-2 and MMP-9 expression and inactivation of p38 signaling pathway
- 16 October 2015
- journal article
- research article
- Published by Springer Nature in Tumor Biology
- Vol. 37 (3) , 3831-3839
Abstract
Gliomas are the most common and malignant primary brain tumors. They are associated with a poor prognosis despite the availability of multiple therapeutic options. Naringin, a common dietary flavonoid abundantly present in fruits and vegetables, is believed to possess strong anti-proliferative and anti-cancer properties. However, there are no reports describing its effects on the invasion and migration of glioblastoma cell lines. Our results showed that the treatment of U251 glioma cell lines with different concentrations of naringin inhibited the invasion and migration of these cells. In addition, we revealed a decrease in the levels of matrix metalloproteinases (MMP-2) and (MMP-9) expression as well as proteinase activity in U251 glioma cells. In contrast, the expression of tissue inhibitor of metalloproteinases (TIMP-1) and (TIMP-2) was increased. Furthermore, naringin treatment decreased significantly the phosphorylated level of p38. Combined treatment with a p38 inhibitor (SB203580) resulted in the synergistic reduction of MMP-2 and MMP-9 expressions correlated with an increase of TIMP-1 and TIMP-2 expressions and the anti-invasive properties. However, p38 chemical activator (anisomycin) could block these effects produced by naringin, suggesting a direct downregulation of the p38 signaling pathway. These data suggest that naringin may have therapeutic potential for controlling invasiveness of malignant gliomas by inhibiting of p38 signal transduction pathways.Keywords
Funding Information
- Ministry of Higher Education, Scientific Research (MHESR) - Tunisia (UR11ES70, UR12ES70)
This publication has 48 references indexed in Scilit:
- Naringenin attenuates CCl4‐induced hepatic inflammation by the activation of an Nrf2‐mediated pathway in ratsClinical and Experimental Pharmacology and Physiology, 2014
- Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant gliomaBiochemical and Biophysical Research Communications, 2013
- Ethanol Extracts of Fruiting Bodies ofAntrodia cinnamomeaSuppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt Signaling PathwaysEvidence-Based Complementary and Alternative Medicine, 2012
- A complete compilation of matrix metalloproteinase expression in human malignant gliomasWorld Journal of Clinical Oncology, 2012
- Matrix metalloproteinases in tumorigenesis: an evolving paradigmCellular and Molecular Life Sciences, 2011
- p38γ MAPK Cooperates with c-Jun in trans-Activating Matrix Metalloproteinase 9Journal of Biological Chemistry, 2010
- Naringin Protects against Rotenone-induced Apoptosis in Human Neuroblastoma SH-SY5Y CellsThe Korean Journal of Physiology & Pharmacology, 2009
- Tumor metastasis: mechanistic insights and clinical challengesNature Medicine, 2006
- Matrix metalloproteinases and tumor metastasisCancer and Metastasis Reviews, 2006
- Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells.1993